Spinosad 131929-60-7 — China API Manufacturer | USP/FAO R&D to Production

China Manufacturing Landscape for Spinosad

Spinosad (CAS 131929-60-7) is a naturally derived insecticidal compound produced by fermentation of the soil actinomycete Saccharopolyspora spinosa. Comprising a mixture of spinosyns A and D, Spinosad is widely used in agriculture, veterinary medicine, and public health applications due to its favorable toxicological profile and effectiveness against a broad range of insect pests. China has become one of the world’s largest producers of Spinosad, leveraging its extensive fermentation industry infrastructure and competitive production economics. Our quality-certified manufacturing facility produces high-purity Spinosad technical material and pharmaceutical-grade API for global distribution to crop protection companies, veterinary pharmaceutical formulators, and public health organizations.

China’s strength in Spinosad manufacturing derives from a mature fermentation industry ecosystem that includes strain development laboratories, large-scale bioreactor manufacturing, efficient downstream processing capabilities, and an experienced technical workforce. Domestic production of fermentation media components including soy flour, glucose, and mineral salts at industrial scale further contributes to cost efficiency that positions Chinese Spinosad competitively in global markets.

Manufacturing Process & Facility

Spinosad manufacturing follows a biological fermentation route using proprietary high-yielding strains of Saccharopolyspora spinosa maintained in a qualified cell bank system. The production process begins with seed culture preparation through sequential inoculum stages, expanding from laboratory shake flasks through pilot-scale fermenters to production-scale bioreactors of up to 100,000 liters capacity. Fermentation conditions including temperature (30±1°C), aeration rate, agitation speed, and nutrient feeding profiles are precisely controlled via automated DCS systems to optimize spinosyn yield and the A/D ratio.

Harvesting involves whole-broth extraction with suitable organic solvents, followed by liquid-liquid partitioning, adsorption chromatography, and crystallization steps to isolate and purify the active spinosyn components. The spinosyn A to spinosyn D ratio is maintained within specification through fermentation control rather than post-purification blending, ensuring authentic biosynthetic product composition. The facility features stainless steel fermenters, centrifugal separators, multi-stage extraction trains, and dedicated solvent recovery systems, with annual production capacity exceeding 500 metric tons of technical-grade Spinosad.

Quality Standards & Multi-Pharmacopeial Compliance

Spinosad produced at our facility is available in both technical grade (meeting FAO specifications for crop protection applications) and pharmaceutical grade (meeting USP requirements for veterinary and human health uses). The pharmaceutical-grade product maintains spinosyn A content of 50-95% and spinosyn D content of 5-50% by HPLC, with total spinosyn A+D content exceeding 85%. Related impurity levels are controlled below specified limits through validated chromatographic methods.

Quality testing encompasses HPLC assay and impurity profiling, residual solvent analysis, water content by Karl Fischer, heavy metals by ICP-MS, microbial limits testing, and particle size distribution analysis. For agricultural-grade material, additional testing includes emulsifiability, suspensibility, and wettability assessments per FAO/WHO JMPS guidelines. Stability studies under ICH-aligned conditions support a 36-month shelf life for properly stored material.

Regulatory Documentation

Regulatory documentation packages are tailored to end-use market requirements. For veterinary pharmaceutical applications, we provide Drug Master Files in CTD format, quality certificates, and full analytical method validation reports. For agricultural applications, we supply technical dossiers compliant with FAO/WHO JMPS specifications, equivalence study data packages per FAO guidelines, five-batch analysis reports, and toxicological summaries. Additional documentation includes manufacturing process flow diagrams, quality management system certificates (ISO 9001 and ISO 14001), and product-specific MSDS in GHS format for all destination countries.

Packaging & Logistics

Spinosad is packaged according to end-use grade and customer requirements. Pharmaceutical-grade material is supplied in double PE-lined fiber drums of 10 kg or 25 kg net weight. Technical-grade material is available in 25 kg fiber drums, 200 kg steel drums, or 500 kg flexible intermediate bulk containers (FIBCs) for large-volume shipments. All packaging meets UN transportation requirements for the applicable hazard classification. Shipments are arranged via sea freight (20-30 days to major ports) for bulk orders and air freight (5-10 days) for urgent or sample quantities. Full export documentation, including phytosanitary certificates and fumigation certificates where required, is provided.

Competitive Pricing & Supply Reliability

Competitive pricing for Spinosad reflects significant scale advantages of our high-capacity fermentation facility. Volume-based pricing tiers are available from development quantities (1-10 kg) through commercial volumes (multi-ton annual contracts). Long-term supply agreements with indexed pricing provide customers with budget predictability while maintaining competitive cost structures. Standard production lead times are 4-8 weeks depending on grade and quantity, with expedited scheduling available for established customers. Our production planning team coordinates with customers’ forecast schedules to ensure just-in-time delivery alignment with formulation campaign requirements.

Spinosad Specifications